Intravenous Magnesium in Patients Receiving Cisplatin
NCT04481672
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Mesothelioma
Interventions
DRUG:
Magnesium Sulfate
Sponsor
Dana-Farber Cancer Institute